165 results
Page 3 of 9
8-K
EX-99.1
57n795a
24 Aug 21
Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients
8:29am
8-K
1704msm6 00bz9
23 Apr 21
Bio-Path Announces Publication in Biomedicines
5:25pm
8-K
EX-99.1
lje 1c0gu
23 Apr 21
Bio-Path Announces Publication in Biomedicines
5:25pm
8-K
EX-99.1
1mcqf w1hsrz5n67w
17 Feb 21
Placement Agency Agreement
5:11pm
8-K
EX-10.1
oqhsy3d mm0
17 Feb 21
Placement Agency Agreement
5:11pm
8-K
EX-99.1
2omma7oc3
19 Nov 20
Bio-Path Holdings Announces First Patient Dosed in Phase 1 Clinical Trial of BP1002
4:30pm
8-K
EX-10.1
nmg9z
14 Jul 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-99.1
vtfm5gk6rpqqa4jw0f
6 Mar 20
Bio-path Holdings Reports Full Year 2019 Financial Results
7:10am